Breadcrumb
NIH Guide: Weekly Index for July 10, 2020
Weekly NIH Funding Opportunities and Notices
July 10, 2020
General Notices
-
Notice of Early Expiration of "Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Research on Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
(NOT-AI-20-058)National Institute of Allergy and Infectious Diseases
-
Notice Announcing the National Institute of Mental Health (NIMH) Expectations for Collection of Common Data Elements
(NOT-MH-20-067)National Institute of Mental Health
-
RESCINDED - Guidance for Applicants Preparing Applications for the Fall 2020 Due Dates During the COVID-19 Pandemic
(NOT-OD-20-122)National Institutes of Health
-
Request for Information (RFI): Seeking Stakeholder Input on Scientific Gaps and Research Needs Related to Delivery of Cancer-related Care via Telehealth
(NOT-CA-20-080)National Cancer Institute
Notice of Changes to Funding Opportunities
-
Notice to Extend the Expiration Date for PAR-17-287 "NIA Academic Leadership Career Award (K07)"
(NOT-AG-20-042)National Institute on Aging
-
Notice of NIAMS Participation in PA-20-135, "Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional)"
(NOT-AR-20-020)National Institute of Arthritis and Musculoskeletal and Skin Diseases
-
Notice of Participation of NCCIH in PAR-19-342, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Institutionally-Focused Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)"
(NOT-AT-20-018)National Center for Complementary and Integrative Health
-
Notice of Participation of NCCIH in PAR-19-343, "Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Not Allowed)"
(NOT-AT-20-019)National Center for Complementary and Integrative Health
-
Notice of Clarification to Key Dates for RFA-CA-20-039 "Emergency Awards: Research Projects in SARS-CoV-2 Serological Sciences (U01 Clinical Trial Optional)"
(NOT-CA-20-076)National Cancer Institute
-
Notice of Changes to the Dates in the Final Receipt, Review, Council, and Award Cycle and to the Expiration Date of PAR-19-101, "Physical Sciences-Oncology Network (PS-ON): Physical Sciences-Oncology Projects (PS-OP) (U01 Clinical Trial Optional)"
(NOT-CA-20-084)National Cancer Institute
-
Notice to Add a Receipt Date to RFA-DA-21-019 Single Cell Opioid Responses in the Context of HIV (SCORCH) Program Expansion: CNS Data Generation for Chronic Opioid, Methamphetamine, and/or Cocaine Exposures (U01 Clinical Trial Not Allowed)
(NOT-DA-20-063)National Institute on Drug Abuse
-
Notice of Change to Application Receipt Dates and Clarification of Eligibility Information for PAR-20-220, Institutional Network Award for Promoting Kidney, Urologic, and Hematologic Research Training (U2C-Clinical Trial Not Allowed)
(NOT-DK-20-038)National Institute of Diabetes and Digestive and Kidney Diseases
-
Notice of Change to Instructions for Human Subjects and Clinical Trial Information in PAR-19-312 Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 Clinical Trial Optional)"
(NOT-GM-20-035)National Institute of General Medical Sciences
-
Notice of Change to Instructions for Human Subjects and Clinical Trial Information in PAR-19-313 "Centers of Biomedical Research Excellence (COBRE) Phase 1 (P20 Clinical Trial Optional)
(NOT-GM-20-040)National Institute of General Medical Sciences
-
Notice to Extend Response Date for NOT-GM-20-034: "Request for Information: Soliciting Input on the NIGMS 2021-2025 Strategic Plan Framework"
(NOT-GM-20-044)National Institute of General Medical Sciences
-
Notice of Additional Eligibility Information in PAR-20-100 Genomic Community Resources (U24)
(NOT-HG-20-050)National Human Genome Research Institute
-
Notice of Participation in PA-18-358, "NINDS Exploratory Neuroscience Research Grant (R21- Clinical Trial Optional)"
(NOT-MH-20-034)National Institute of Mental HealthNational Institute of Neurological Disorders and Stroke
-
Notice of New Budget Limitation for PAR-18-657 "Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)"
(NOT-NS-20-085)National Institute of Neurological Disorders and StrokeNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Institute of Environmental Health SciencesNational Eye Institute
-
Notice of Change to Key Dates for PAR-18-657 "Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)".
(NOT-NS-20-086)National Institute of Neurological Disorders and StrokeNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Institute of Environmental Health SciencesNational Eye Institute
-
Notice of Change to Key Dates for PAR-19-039 "Countermeasures Against Chemical Threats (CounterACT): Identification of Therapeutic Lead Compounds (U01 Clinical Trial Not Allowed)"
(NOT-NS-20-087)National Institute of Neurological Disorders and StrokeNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Institute of Environmental Health SciencesNational Eye Institute
-
Notice of Change to Key Dates for PAR-19-040 "Countermeasures Against Chemical Threats (CounterACT): Optimization of Therapeutic Lead Compounds (U01 Clinical Trial Optional)"
(NOT-NS-20-088)National Institute of Neurological Disorders and StrokeNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Institute of Environmental Health SciencesNational Eye Institute
-
Notice of Clarification to Application Types Allowed PAR-20-111 "Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)"
(NOT-NS-20-091)National Institute of Neurological Disorders and Stroke
-
Notice of Change to Key Dates for RFA-NS-20-030 "Research Program Award (R35 Clinical Trial Optional)"
(NOT-NS-20-092)National Institute of Neurological Disorders and Stroke
Notices of Intent to Publish
-
Notice of Intent to Publish a Funding Opportunity Announcement for ALACRITY Centers for Practice-Based Effectiveness and Services Research with Near-Term Impact (P50 Clinical Trial Optional)
(NOT-MH-20-070)National Institute of Mental Health
-
Notice of Intent to Publish Funding Opportunity Announcements for the RADx-rad Initiative
(NOT-OD-20-144)National Institutes of HealthNational Institute on Deafness and Other Communication Disorders
Notices of Special Interest
-
Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19)
(NOT-AI-20-059)National Institute of Allergy and Infectious Diseases
-
Notice of Special Interest (NOSI): National Cancer Institute (NCI) Emergency Administrative Supplements for Research and Training Continuity of Postdoctoral Fellows during Coronavirus Disease 2019 (COVID-19)
(NOT-CA-20-082)National Cancer Institute
Funding Opportunities
-
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31-Diversity)
(PA-20-251)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Drug AbuseNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Library of MedicineNational Institute of Mental HealthNational Institute of Nursing ResearchNational Institute of Neurological Disorders and StrokeNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Institute on Minority Health and Health DisparitiesDivision of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure ProgramsApplication Receipt Date(s): Standard dates apply, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance (SB1, Clinical Trial Not Allowed)
(PAR-20-128)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Cancer InstituteNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Institute of Environmental Health SciencesNational Eye InstituteNational Human Genome Research InstituteNational Heart, Lung, and Blood InstituteNational Library of MedicineNational Institute of Mental HealthNational Center for Advancing Translational SciencesNational Center for Complementary and Integrative HealthNational Institute of Biomedical Imaging and BioengineeringNational Center for Advancing Translational SciencesApplication Receipt Date(s): All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1, Clinical Trial Not Allowed)
(PAR-20-129)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute of General Medical SciencesNational Institute on Deafness and Other Communication DisordersNational Institute of Dental and Craniofacial ResearchNational Institute of Diabetes and Digestive and Kidney DiseasesNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Standard dates apply All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
SBIR/STTR Commercialization Readiness Pilot (CRP) Program Technical Assistance and Late Stage Development (SB1 Clinical Trial Required)
(PAR-20-130)National Institutes of HealthNational Institute on Alcohol Abuse and AlcoholismNational Institute on AgingNational Institute on Deafness and Other Communication DisordersNational Eye InstituteEunice Kennedy Shriver National Institute of Child Health and Human DevelopmentNational Heart, Lung, and Blood InstituteNational Institute of Mental HealthNational Institute of Neurological Disorders and StrokeApplication Receipt Date(s): Standard dates apply All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s). Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
-
Countermeasures Against Chemical Threats (CounterACT) Exploratory/Developmental Projects (R21 Clinical Trial Not Allowed)
(PAR-20-253)National Institute of Neurological Disorders and StrokeNational Institute of Allergy and Infectious DiseasesNational Institute of Arthritis and Musculoskeletal and Skin DiseasesNational Institute on Drug AbuseNational Institute of Environmental Health SciencesNational Eye InstituteApplication Receipt Date(s): May 26, 2021; May 31, 2022; May 30, 2023, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
-
Tobacco Use and HIV in Low and Middle-Income Countries (U01 Clinical Trial Optional)
(RFA-CA-20-037)National Cancer InstituteApplication Receipt Date(s): Only accepting applications for the AIDS Application Due Date(s) listed below.
-
Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Clinical Centers (U01 Clinical Trial Required)
(RFA-DK-20-011)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): November 4, 2020
-
Caring for OutPatiEnts after Acute Kidney Injury (COPE-AKI) Scientific and Data Research Center (U01 Clinical Trial Required)
(RFA-DK-20-012)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): November 4, 2020
-
Mechanistic Studies of the Interaction between SARS-CoV-2/COVID-19 and Diseases and Organ Systems of Interest to NIDDK (R01 Clinical Trial Optional)
(RFA-DK-20-021)National Institute of Diabetes and Digestive and Kidney DiseasesApplication Receipt Date(s): December 16, 2020
-
Development of Standard Core Clinical Outcomes Assessments (COAs) and Endpoints (UG3/UH3 Clinical Trial Optional)
(RFA-FD-21-004)Food and Drug AdministrationApplication Receipt Date(s): October 14, 2020, by 11:59 PM Eastern Time. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Applicants should be aware that on-time submission means that an application is submitted error free (of both Grants.gov and eRA Commons errors) by 11:59 PM Eastern Time on the application due date. Late applications will not be accepted for this FOA.
NIH Funding Opportunities are also available in an RSS feed (Really Simple Syndication).
Subscribe/Unsubscribe from the NIH Guide Weekly TOC LISTSERV.
This page last updated on: April 17, 2025
For technical issues E-mail OER Webmaster